LakeShore Biopharma Net Income vs. EBITDA
| LSBPW Stock | 0.04 0.00 0.00% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -433.5 M | Current Value -411.8 M | Quarterly Volatility 88.3 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.62 | 0.7948 |
|
|
For LakeShore Biopharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of LakeShore Biopharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well LakeShore Biopharma Co, utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between LakeShore Biopharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of LakeShore Biopharma Co, over time as well as its relative position and ranking within its peers.
LakeShore |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LakeShore Biopharma. If investors know LakeShore will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LakeShore Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of LakeShore Biopharma Co, is measured differently than its book value, which is the value of LakeShore that is recorded on the company's balance sheet. Investors also form their own opinion of LakeShore Biopharma's value that differs from its market value or its book value, called intrinsic value, which is LakeShore Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LakeShore Biopharma's market value can be influenced by many factors that don't directly affect LakeShore Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LakeShore Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if LakeShore Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LakeShore Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
LakeShore Biopharma Co, EBITDA vs. Net Income Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining LakeShore Biopharma's current stock value. Our valuation model uses many indicators to compare LakeShore Biopharma value to that of its competitors to determine the firm's financial worth. LakeShore Biopharma Co, is currently regarded as number one stock in net income category among its peers. It also is currently regarded as number one stock in ebitda category among its peers . LakeShore Biopharma reported Net Loss of (433.46 Million) in 2023. Comparative valuation analysis is a catch-all technique that is used if you cannot value LakeShore Biopharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.LakeShore EBITDA vs. Net Income
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
LakeShore Biopharma |
| = | (433.46 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
LakeShore Biopharma |
| = | (368.66 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
LakeShore EBITDA Comparison
LakeShore Biopharma is currently under evaluation in ebitda category among its peers.
LakeShore Biopharma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in LakeShore Biopharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, LakeShore Biopharma will eventually generate negative long term returns. The profitability progress is the general direction of LakeShore Biopharma's change in net profit over the period of time. It can combine multiple indicators of LakeShore Biopharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -58.2 M | -55.3 M | |
| Net Interest Income | -44.3 M | -42.1 M | |
| Operating Income | -445.8 M | -423.5 M | |
| Net Loss | -433.5 M | -411.8 M | |
| Income Before Tax | -455.2 M | -432.4 M | |
| Total Other Income Expense Net | -9.4 M | -9.8 M | |
| Net Loss | -433.5 M | -411.8 M | |
| Income Tax Expense | -21.7 M | -20.6 M | |
| Income Quality | 0.68 | 1.33 | |
| Net Income Per E B T | 0.95 | 1.13 |
LakeShore Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on LakeShore Biopharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of LakeShore Biopharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the LakeShore Biopharma's important profitability drivers and their relationship over time.
| Net Income vs Revenue | ||
| Total Debt vs EBITDA | ||
| Net Income vs Cash Flow From Operations | ||
| Number Of Employees vs EBITDA | ||
| Net Income vs Total Asset | ||
| Retained Earnings vs EBITDA | ||
| Net Income vs Working Capital |
Use LakeShore Biopharma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if LakeShore Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LakeShore Biopharma will appreciate offsetting losses from the drop in the long position's value.LakeShore Biopharma Pair Trading
LakeShore Biopharma Co, Pair Trading Analysis
The ability to find closely correlated positions to LakeShore Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace LakeShore Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back LakeShore Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling LakeShore Biopharma Co, to buy it.
The correlation of LakeShore Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as LakeShore Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if LakeShore Biopharma Co, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for LakeShore Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your LakeShore Biopharma position
In addition to having LakeShore Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Books Thematic Idea Now
Books
Companies involved in publishing of books, newspapers, periodicals and other mass publications. The Books theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Books Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for LakeShore Stock Analysis
When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.